Early administration of the glucose-dependent insulinotropic polypeptide receptor antagonist (Pro3)GIP prevents the development of diabetes and related metabolic abnormalities associated with genetically inherited obesity inob/obmice

✍ Scribed by N. Irwin; P. L. McClean; F. P. M. O’Harte; V. A. Gault; P. Harriott; P. R. Flatt

• Publisher: Springer
• Year: 2007
• Tongue: English
• Weight: 216 KB
• Volume: 50
• Category: Article
• ISSN: 0012-186X
• DOI: 10.1007/s00125-007-0692-2